Oroborus
  • Home
  • Helix
  • GPCR
  • Our Name
  • Contact
  • More
    • Home
    • Helix
    • GPCR
    • Our Name
    • Contact
Oroborus
  • Home
  • Helix
  • GPCR
  • Our Name
  • Contact
Bim peptide bound to Bcl-xL PDB:3FDL

Drug Building Technologies

Drug Building TechnologiesDrug Building TechnologiesDrug Building Technologies

Oroborus uses a mimetic approach to drug development. Our technologies allow a cut and paste approach to new drug leads

About Us

Why us?

We aim to provide best-in-class technology 

or high value approaches.

The Company

Oroborus is a private company based in Brisbane, Australia.  It was founded in 2012 to develop chemical technology for making peptide mimetics. Our technology is wholly owned by the company with no outside academic or commercial rights or encumbrances (as of 2019).

The Founder

Oroborus  was founded by Peter Cassidy, an organic and medicinal chemist with over 20 years experience developing peptide mimetics.  Peter holds a first class honours degree and PhD from the University of Queensland.  He has prior experience raising commercial and grant funds, and has won a number of academic awards. His previous company placed a molecule into Phase II clinical trials.

Copyright © 2023 Oroborus - All Rights Reserved.

Powered by GoDaddy Website Builder